Trending/aducanumab

Drugmaker presents data on new Alzheimer’s drug
The company that makes aducanumab for Alzheimer's disease says that the drug slows mental decline. Biogen Inc. revealed its new analyses of data from its phase 3…
Special Topics
Sign up

Social Media Network
A network for digital healthcare communicators

Mayo Clinic Connect
An online patient support community